TITLE

Vascular pathology as a result of drug-eluting stents

AUTHOR(S)
Bennett, Martin R.
PUB. DATE
August 2007
SOURCE
Heart;Aug2007, Vol. 93 Issue 8, p895
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article discusses the result of drug-eluting stents (DES) on vascular pathology. The implantation rates of drug-eluting stents comprise 60% of stent implants in Great Britain as shown in a study in 2005. This rate has been marked in clinical trials showing that restenosis and target lesion revascularisation rates are lower.
ACCESSION #
27040525

 

Related Articles

  • Advances in stent technologies and their effect on clinical efficacy and safety. Nikam, Navin; Steinberg, Toby B.; Steinberg, Daniel H. // Medical Devices: Evidence & Research;2014, Vol. 7, p165 

    The introduction of intracoronary stents represented a major advance in interventional cardiology. While bare metal stents set the benchmark for improved safety over angioplasty, intimal hyperplasia and subsequent restenosis were important limitations. First-generation drug-eluting stents...

  • Sirolimus-eluting stent reduced risk for restenosis.  // Endocrine Today;4/10/2008, Vol. 6 Issue 6, p24 

    The article reports that researchers from Italy found out that sirolimus-eluting stents decrease the risk for restenosis. The study involves 60 patients assigned to sirolimus-eluting stent and 60 patients to paclitaxel-eluting stent. It shows that patients had lower in-stent luminal loss and the...

  • RESTENOSIS AFTER BALLOON ANGIOPLASTY AND/OR STENT INSERTION--ORIGIN AND PREVENTION. Ćwikiel, W. // Acta Radiologica;Sep2002, Vol. 43 Issue 5, p442 

    Discusses the origin and prevention of restenosis after percutaneous transluminal angioplasty (PTA) or insertion of vascular metallic endoprostheses, or stents. Effects of PTA and stent insertion; Development of intimal hyperplasia (IH) and its prevention.

  • Sirolimus.  // Reactions Weekly;4/7/2007, Issue 1146/1147, p23 

    This article presents a case study of a 59-year-old man, with in-stent restenosis of a bare metal stent, who developed late restenosis after sirolimus-eluting stent deployment. After initial angioplasty and two overlapping sirolimus-eluting stents were placed in his left anterior descending...

  • Sirolimus.  // Reactions Weekly;8/25/2012, Issue 1416, p40 

    The article describes the case of a 56-year-old man who developed in-stent restenosis of receiving a sirolimus-eluting stent.

  • Increased Platelet Indices in Acute Stent Thrombosis. Cetin, Mustafa; Balli, Mehmet; Tasolar, Hakan; Cakici, Musa; Bakirci, Eftal Murat // Angiology;Sep2014, Vol. 65 Issue 8, p745 

    A response from the author of the article "Increased platelet distribution width is associated with st-segment elevation myocardial infarction and thrombolysis failure" in 2014 issue is presented.

  • Prevention of restenosis: is angioplasty the answer? Scheller, Bruno; Speck, Ulrich; Böhm, Michael // Heart;May2007, Vol. 93 Issue 5, p539 

    The author focuses on the topic of restenosis prevention. Approaches using systemic antiproliferation agents have failed to prevent restenosis after percutaneous coronary interventions. Thus, prevention of restenosis continues to be a challenge to interventional cardiology. Clinical trials on...

  • Residual Stenosis Poststenting and Subsequent Decrease in the Proximal Reference Diameter Are Correlated: Excessive Axial Wall Stress Is a Plausible Explanation. Doriot, Pierre-André; Dorsaz, Pierre-André // Journal of Endovascular Therapy (Allen Press Publishing Services;Jun2004, Vol. 11 Issue 3, p310 

    Purpose: To test the hypothesis that edge restenosis in stented lesions might be due to an increase in axial wall stress in the adjacent proximal vessel segment by examining whether the proximal reference diameters of conventionally stented lesions are reduced at follow-up and whether this...

  • Cilostazol Inhibits Leukocyte Integrin Mac-1, Leading to a Potential Reduction in Restenosis After Coronary Stent Implantation. Clagett, G. Patrick // Perspectives in Vascular Surgery & Endovascular Therapy;Sep2005, Vol. 17 Issue 3, p265 

    The study was conducted to determine if cilostazol inhibits leukocyte Mac-1, leading to prevention of poststent restenosis. Cilostazol inhibits platelet phosphodiesterase III as well as α-granule release of P-selection in platelets, which have a key role in the upregulation of leucocyte...

  • PAINT.  // Herz;Jul2008, Vol. 33 Issue 5, p385 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics